No Data
National medical insurance drug list unveiling soon! Keji Pharmaceutical's stock surged over 9%, leading the way in Hong Kong pharmaceutical stocks.
1. What is the importance of centralized procurement of pharmaceutical companies by medical insurance? 2. Which areas of products are expected to be included in the 2024 National Medical Insurance Drug Catalog?
Hong Kong stocks are moving differently | Most pharmaceutical stocks are rising as the results of the medical insurance negotiations are about to be revealed. Institutions indicate that the sector still has further room for recovery.
Most pharmaceutical stocks are rising, as of the deadline, Keji Pharmaceutical-B (02171) rose by 12.38%, to 7.71 Hong Kong dollars; innocare (09969) rose by 5.36%, to 6.49 Hong Kong dollars; Kainuo Ya-B (02162) rose by 4.3%, to 41.25 Hong Kong dollars.
Express News | Lakeside Holding;s Hupan Pharmaceutical Partners With Sinopharm Group Hubei
Lakeside Strengthens Market Position in China's Pharmaceutical Logistics With Key Sinopharm(Hubei) Contracts
Sinopharm Group Reports Nine-Month Financial Results
Sinopharm Group Reports Mixed Financial Results
No Data
No Data
Cui Nyonya Kueh :
Musang Siguntang : ???